Bing Chen
Direktor/Vorstandsmitglied bei Continent Pharmaceutical Inc.
Profil
Bing Chen is currently an Independent Non-Executive Director at Continent Pharmaceutical Inc. and an Independent Non-Executive Director at Beijing Continent Pharmaceutical Co., Ltd.
He is also a Director at Shanghai Ennovabio Pharmaceuticals Co. Ltd., Chengdu Talend Medical Technology Co. Ltd., Xian Kontour Medical Technology Co. Ltd., and a Supervisor at Ningbo Taikang Pharmaceutical Technology Co. Ltd.
Previously, he was a Director at Kontour (Xi'an) Medical Technology Co., Ltd., Suzhou Kintor Pharmaceuticals, Inc., Genfleet Therapeutics (Shanghai), Inc., and Zylox-Tonbridge Medical Technology Co., Ltd.
He was also a Non-Executive Director at Kintor Pharmaceutical Ltd.
from 2019 to 2021.
Additionally, he served as a Member-Supervisory Board at Sansure Biotech, Inc. Dr. Chen received his undergraduate, graduate, and doctorate degrees from Tsinghua University and a doctorate degree from Peking Union Medical College.
Aktive Positionen von Bing Chen
Unternehmen | Position | Beginn |
---|---|---|
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | Direktor/Vorstandsmitglied | 01.01.2019 |
Ningbo Taikang Pharmaceutical Technology Co. Ltd.
Ningbo Taikang Pharmaceutical Technology Co. Ltd. Packaged SoftwareTechnology Services Ningbo Taikang Pharmaceutical Technology Co. Ltd. is a private company that develops pharmaceutical technology. The company is based in Ningbo, China. | Direktor/Vorstandsmitglied | - |
Shanghai Ennovabio Pharmaceuticals Co. Ltd.
Shanghai Ennovabio Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ennovabio Pharmaceuticals Co. Ltd. is a private company that manufactures pharmaceutical products. The company is based in Shanghai, China. | Direktor/Vorstandsmitglied | - |
Chengdu Talend Medical Technology Co. Ltd. | Direktor/Vorstandsmitglied | - |
Xian Kontour Medical Technology Co. Ltd. | Direktor/Vorstandsmitglied | - |
Beijing Continent Pharmaceutical Co., Ltd.
Beijing Continent Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Continent Pharmaceutical Co. Ltd. is a commercial-stage biopharmaceutical company committed to the research, development and commercialization of innovative drugs for organ fibrosis for two decades. The firm focuses on idiopathic pulmonary fibrosis (“IPF”) and have gradually broadened therapeutic field and research & development efforts to other areas of organ fibrosis. The company flagship product ETUARY (pirfenidone capsule) was approved in China in 2011 and is among the first three approved drugs for IPF worldwide. The firm has developed a pipeline of additional four innovative drug candidates, and amassed eight-years’ experience of successful commercialization. The company was founded in July 2002 and is headquartered in Beijing, China. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Bing Chen
Unternehmen | Position | Ende |
---|---|---|
KINTOR PHARMACEUTICAL LIMITED | Direktor/Vorstandsmitglied | 30.04.2021 |
Kontour (Xi'an) Medical Technology Co., Ltd.
Kontour (Xi'an) Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Kontour (Xi'an) Medical Technology Co., Ltd. engages in the research and development, production, and sales service of three types of implanted medical devices. Its products include neurosurgery products, cardiothoracic surgery products, neurospine products, and oral implant system. Its products are used in neurosurgery, skull repair, and cardiothoracic surgery. The company was founded by Li Ren Hu, Li Gong Hu and Di Yuan Huang on March 14, 2005 and is headquartered in Xi'an, China. | Direktor/Vorstandsmitglied | - |
ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. | Direktor/Vorstandsmitglied | - |
░░░░░░ ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Bing Chen
Peking Union Medical College | Doctorate Degree |
Tsinghua University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
SANSURE BIOTECH INC. | Health Technology |
ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. | Health Technology |
KINTOR PHARMACEUTICAL LIMITED | Health Technology |
Health Technology |
Private Unternehmen | 8 |
---|---|
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | Health Technology |
Ningbo Taikang Pharmaceutical Technology Co. Ltd.
Ningbo Taikang Pharmaceutical Technology Co. Ltd. Packaged SoftwareTechnology Services Ningbo Taikang Pharmaceutical Technology Co. Ltd. is a private company that develops pharmaceutical technology. The company is based in Ningbo, China. | Technology Services |
Genfleet Therapeutics (Shanghai), Inc.
Genfleet Therapeutics (Shanghai), Inc. Miscellaneous Commercial ServicesCommercial Services Genfleet Therapeutics (Shanghai), Inc. is a Chinese clinical-stage biotechnology company that focuses on developing novel drug candidates for unmet medical needs in oncology and immunology. The company is based in Shanghai, China, and was founded in 2017 by Jiong Lan and Qiang Lü. The company has built up industry-leading capabilities and expertise in developing both small molecules and biologics since its inception in 2017. Genfleet's proprietary and fully integrated R&D platform highlights multiple cutting-edge products with novel mechanisms and IP. The company's pipeline includes over 10 programs, many of which have entered multi-regional clinical trials across China. Genfleet has completed co-development partnerships with a number of publicly listed companies worldwide. Jiong Lan has been the CEO since 2017. | Commercial Services |
Shanghai Ennovabio Pharmaceuticals Co. Ltd.
Shanghai Ennovabio Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ennovabio Pharmaceuticals Co. Ltd. is a private company that manufactures pharmaceutical products. The company is based in Shanghai, China. | Health Technology |
Chengdu Talend Medical Technology Co. Ltd. | |
Xian Kontour Medical Technology Co. Ltd. | |
Suzhou Kintor Pharmaceuticals, Inc.
Suzhou Kintor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Suzhou Kintor Pharmaceuticals, Inc. engages in the technology research and development, technical services, transfer, and advice of drugs and reagents. The company was founded by Youzhi Tong on March 24, 2009 and is headquartered in Suzhou, China. | Health Technology |
Beijing Continent Pharmaceutical Co., Ltd.
Beijing Continent Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Continent Pharmaceutical Co. Ltd. is a commercial-stage biopharmaceutical company committed to the research, development and commercialization of innovative drugs for organ fibrosis for two decades. The firm focuses on idiopathic pulmonary fibrosis (“IPF”) and have gradually broadened therapeutic field and research & development efforts to other areas of organ fibrosis. The company flagship product ETUARY (pirfenidone capsule) was approved in China in 2011 and is among the first three approved drugs for IPF worldwide. The firm has developed a pipeline of additional four innovative drug candidates, and amassed eight-years’ experience of successful commercialization. The company was founded in July 2002 and is headquartered in Beijing, China. | Health Technology |